Regulated proteolysis is required to execute many cellular programs. In Caulobacter crescentus, timely degradation of the master regulator CtrA by ClpXP protease is essential for cell-cycle progression and requires the colocalization of CtrA and RcdA. Here, we establish a biochemical framework to understand regulated proteolysis in C. crescentus and show that RcdA is not an adaptor for CtrA degradation. CtrA is rapidly degraded without RcdA and is recognized with an affinity comparable with the best ClpXP substrates. In contrast, SspB␣, the ␣-proteobacterial homolog of SspB, functions as an adaptor to enhance degradation of specific substrates. Cargo-free SspB␣ is also itself a substrate of ClpXP-mediated proteolysis. Thus, our analysis (i) reveals the consequences of both direct and adaptorstimulated recognition in mediating substrate specificity in vitro, (ii) reveals a potential regulatory role of controlled adaptor stability, and (iii) suggests that cell-cycle regulation of CtrA stability depends on repression of its intrinsic degradation rather than adaptor-mediated enhancement.
Regulated proteolysis is required to execute many cellular programs. In Caulobacter crescentus, timely degradation of the master regulator CtrA by ClpXP protease is essential for cell-cycle progression and requires the colocalization of CtrA and RcdA. Here, we establish a biochemical framework to understand regulated proteolysis in C. crescentus and show that RcdA is not an adaptor for CtrA degradation. CtrA is rapidly degraded without RcdA and is recognized with an affinity comparable with the best ClpXP substrates. In contrast, SspB␣, the ␣-proteobacterial homolog of SspB, functions as an adaptor to enhance degradation of specific substrates. Cargo-free SspB␣ is also itself a substrate of ClpXP-mediated proteolysis. Thus, our analysis (i) reveals the consequences of both direct and adaptorstimulated recognition in mediating substrate specificity in vitro, (ii) reveals a potential regulatory role of controlled adaptor stability, and (iii) suggests that cell-cycle regulation of CtrA stability depends on repression of its intrinsic degradation rather than adaptor-mediated enhancement.
ClpP ͉ regulated degradation ͉ ClpX R egulated degradation of substrates is important for quality control, control of gene expression, and signaling in many organisms. Specifying which substrates garner a larger share of proteolytic attention is especially critical when cells undergo differentiation or experience rapid changes in their environment. Because degradation is irreversible, robust mechanisms controlling proteolysis are essential. These mechanisms include requiring a specific posttranslational cleavage event before initiating proteolysis, keeping the substrate and protease separate until proteolysis is necessary, and using adaptor proteins to enhance degradation by tethering substrates to their cognate proteases (reviewed in refs. [1] [2] [3] [4] .
ClpXP is an AAAϩ protease involved in regulated proteolysis. ClpXP is composed of either one or two hexamers of the ClpX ATPase bound to a tetradecamer of the ClpP peptidase. Substrates are initially recognized by ClpX, which then uses ATP hydrolysis to power the unfolding and translocation of these substrates through a central pore and into the degradation chamber of ClpP (5, 6) . The presence of short N-or C-terminal peptide recognition motifs (degradation tags) is an important determinant of ClpXP substrate specificity (7) (8) (9) .
Protein degradation by ClpXP is essential in Caulobacter crescentus (10) , an ␣-proteobacterium that undergoes a complex developmental program (Fig. 1A) . For example, CtrA, an essential protein that regulates transcription of cell-cycle-regulated genes and inhibits initiation of DNA replication, is periodically degraded during the cell cycle in a manner dependent on clpX and clpP (10) (11) (12) (13) . Genetic and cell biological experiments have established that regulated degradation of CtrA involves other cellular factors, such as RcdA, a protein that has many of the properties expected of a substrate-specific protease adaptor. Mutants defective in RcdA no longer degrade CtrA, although other ClpXP substrates are unaffected (14) . Furthermore, RcdA, CtrA, and ClpXP colocalize at the time in the cell cycle when CtrA is degraded, and coimmunoprecipitation experiments show that RcdA associates with both CtrA and ClpX in vivo (14) .
There are two well characterized ClpX adaptors: RssB, which delivers S (15) , and SspB, which helps Escherichia coli ClpXP degrade certain substrates (16) . In eubacteria, faulty mRNAs result in stalled ribosomes that are cleared through a process that removes the translational block while simultaneously adding a degradation tag (called the ssrA tag) to the C terminus of the nascent polypeptide (17) . ssrA-tagged substrates are targeted to ClpXP and other proteases in the absence of adaptors (18) , but SspB tethers these substrates to ClpXP, increasing the efficiency of recognition and degradation (19, 20) . SspB also serves as an adaptor for some endogenous E. coli proteins (21, 22) . SspB is ubiquitous in ␥-and ␤-proteobacteria, and proteins with sequence homology (designated here as SspB␣) are present in C. crescentus and other ␣-proteobacteria. It has recently been shown that C. crescentus SspB␣ (encoded by the CC2102 gene and adjacent to the ssrA gene) associates with ssrA-tagged proteins and that strains lacking SspB␣ have deficiencies in degrading ssrA-tagged substrates (23) .
C. crescentus uses a rich array of regulatory strategies to control turnover of specific proteins at the right time and place, but understanding of the molecular mechanisms that regulate ClpXP degradation in this bacterium has been hampered by the absence of an in vitro system. Here, we purify C. crescentus ClpX and ClpP and examine ClpXP degradation of substrates in reactions with and without auxiliary factors. We demonstrate that ClpXP alone is sufficient for robust degradation of CtrA in vitro. Moreover, because RcdA does not enhance ClpXP degradation of CtrA, other mechanisms likely control CtrA degradation in the cell. We also characterize SspB␣ and find, as expected, that it enhances ClpXP degradation of ssrA-tagged substrates by using a tethering mechanism. Unlike its orthologs, however, SspB␣ is itself also degraded by ClpXP, but only in the absence of cargo substrate. Finally, SspB␣ bound to ssrA-tagged substrates potently inhibits the adaptor-independent ClpXP degradation of CtrA. Thus, these results both suggest and constrain models for achieving turnover of specific substrates by AAAϩ proteases during a developmental program.
C-terminal VAA recognition motif (26) (Fig. 1 A) . We found that GFP with the C. crescentus ssrA peptide (AANDNFAEEFAVAA) fused to its C terminus (GFP-CCssrA) was rapidly degraded by C. crescentus ClpXP (Fig. 1B) . Degradation required ATP and did not occur when E. coli ClpP was substituted for C. crescentus ClpP. Mutating the C-terminal AA dipeptide of GFP-CCssrA to DD eliminated degradation (Fig. 1B) .
ClpXP Directly Recognizes CtrA via Its C-Terminal Tag. CtrA also has a C-terminal AA sequence (Fig. 1 A) , which is required for its turnover in C. crescentus (11) . We found that purified CtrA was an excellent substrate for ATP-dependent degradation by C. crescentus ClpXP in vitro (Fig. 1C) , with a K M of 1.2 M and a maximum degradation rate of 3.9 molecules of CtrA per minute per ClpX 6 (Fig. 1D) . Importantly, an AA3DD CtrA mutation, which inhibits ClpXP proteolysis in vivo (11) , also prevented degradation in vitro (Fig. 1C) .
CtrA consists of a C-terminal DNA-binding domain and an N-terminal response regulator receiver domain. The N-terminal domain appears to be important for regulated turnover and polar localization of CtrA in vivo because a variant missing residues 1-116 is not degraded properly (27) . By contrast, we found that a purified CtrA ⌬1-116 protein was degraded rapidly by C. crescentus ClpXP in our in vitro system (Fig. 1E) . Degradation of this truncated CtrA variant was also inhibited by an AA3DD mutation, demonstrating that recognition of the truncated mutant by ClpXP depends on the same C-terminal degradation tag as does the full-length protein. Hence, the N-terminal domain of CtrA is dispensable for direct recognition of this substrate by ClpXP, but the C-terminal tag is crucial.
CtrA Degradation Is Not Stimulated by RcdA. We were surprised to find that purified ClpXP alone degraded CtrA because previous work suggested that RcdA was necessary for proteolysis in vivo (14) . To test directly for adaptor activity, we purified RcdA and assayed its ability to modulate CtrA degradation. Importantly, RcdA did not affect ClpXP-mediated degradation of CtrA in vitro in reactions containing equimolar RcdA and CtrA or a 5-fold excess of RcdA ( Fig. 2A) . Moreover, RcdA did not associate strongly with ClpX, with only trace binding observed in a filter-retention assay (Fig. 2B) . By contrast, the purified SspB␣ adaptor (see below) completely partitioned with ClpX under these conditions (data not shown). To address the possibility that purified RcdA might be denatured, we monitored tryptophan fluorescence as a function of GdnHCl and observed a cooperative melting curve (Fig. 2C) , providing evidence that the RcdA used for our degradation experiments is folded.
CtrA protein needs to be cleared from C. crescentus to permit DNA replication initiation, and it is degraded with a half-life of Ϸ5 min at the G 1 -S transition (11). We asked, therefore, whether the kinetic constants for ClpXP degradation of CtrA in vitro could account for the observed rate of degradation in vivo. Based on estimates of the intracellular concentrations of CtrA (16 Ϯ 3 M in stalked cells; 36 Ϯ 6 M in predivisional cells) (28) and ClpX hexamers (1.6 Ϯ 0.5 M) (29), our kinetic constants predict a degradation half-life between 1 and 5 min. Thus, we conclude that unassisted ClpXP degradation could account for the observed rate of intracellular CtrA degradation without the need to invoke factors that stimulate CtrA degradation in the cell.
SspB␣ Functions as a ClpXP Adaptor. Although RcdA did not appear to function as an adaptor for degradation of CtrA, we considered the possibility that our purified C. crescentus ClpXP enzyme might be damaged in a way that precluded functional interactions with any adaptor. By analogy with well characterized SspB adaptors and homologs (Fig. 3A) , C. crescentus SspB␣ appears to contain a domain of Ϸ100 residues that should bind the ssrA tag of substrates, a variable-length linker, and a short conserved C-terminal peptide (QFRKK) that should tether SspB␣ to ClpX (20) . Therefore we purified C. crescentus SspB␣ and tested its biochemical activities.
SspB␣ bound a peptide corresponding to the C. crescentus ssrA tag (Fig. 3B) with an equilibrium dissociation constant (0.3 M) similar to the value determined for the E. coli protein and ssrA peptide (19) . Importantly, SspB␣ also stimulated degradation of GFP-CCssrA by C. crescentus ClpXP, reducing K M values about Ϸ9-fold and increasing V max values by Ϸ25% (Fig. 3B) . As anticipated, this stimulation required the C-terminal QFRKK of SspB␣ (Fig. 3C) . Thus, SspB␣ binds ssrA-tagged substrates, tethers them to C. crescentus ClpXP, and enhances their degradation as expected from the paradigm established with E. coli orthologs.
Interestingly, SspB␣ was itself degraded, with a half-life of Ϸ2 min, by C. crescentus ClpXP when ssrA-tagged substrates were absent (Fig. 3D Upper) . Abolishing the ability of SspB␣ to tether itself to ClpX by deleting its C-terminal QFRKK eliminated this degradation (data not shown). When GFP-CCssrA was present, however, SspB␣ was essentially stable until this substrate was depleted after 6-8 min, and then it was degraded rapidly (Fig.  3D) . A variant of an ssrA-tagged substrate capable of binding to SspB␣ but unable to serve as a substrate for ClpXP was sufficient to substantially reduce SspB␣ degradation (data not shown), demonstrating that inhibition of degradation by ssrA-tagged substrates is not caused solely by simple substrate competition. Unlike SspB␣, E. coli SspB is not degraded under any circumstances by E. coli ClpXP.
Adaptors Are both Positive and Negative Effectors During Substrate
Choice. The experiments described above highlight cases of degradation mediated by direct tag recognition (e.g., CtrA) and adaptormediated recognition (e.g., SspB␣-enhanced delivery of ssrAtagged substrates). An intriguing extension of these results is that when both adaptor-dependent and adaptor-independent substrates are present, addition of an adaptor should increase degradation of the former protein and decrease degradation of the latter protein through competition (Fig. 4) . Indeed, when saturating quantities of CtrA and GFP-CCssrA were incubated simultaneously with limiting ClpXP, both substrates were degraded. Addition of SspB␣ to this mixture enhanced degradation of GFP-CCssrA, as expected, but substantially reduced the rate of CtrA degradation (Fig. 4) . This experiment highlights the multiple roles, including enhancement and suppression, that adaptor-mediated proteolysis can play in determining the spectrum of substrates degraded in a complex environment like the cell.
Discussion
The life cycle of C. crescentus is dynamic because every cycle of division involves a substantial morphological differentiation, necessitating a major redistribution of proteins (30) . Growing evidence points to an essential role of the AAAϩ family of proteases, including ClpXP (10, 31), in removing proteins that are no longer desired at particular stages of the developmental pathway/cell-cycle. Although it has been intensely studied at the genetic and cellular levels, experiments characterizing the activity of C. crescentus ClpXP in vitro have been lacking. Therefore, we sought to develop and validate a biochemical framework for C. crescentus ClpXP-mediated degradation to understand better the mechanistic underpinning of regulated degradation.
Although ClpXP and related proteases have innate substrate preferences, direct recognition of substrates is limited in its regulatory potential. Adaptor proteins that enhance or alter the substrate-recognition properties of the enzyme provide an additional layer of potential specificity and regulation. The most thoroughly studied AAAϩ protease regulator is the SspB adaptor, which acts to tether specific substrates to ClpXP. Although SspB was initially identified only in ␤-and ␥-proteobacteria (16), it is now clear that a more distantly related homolog (SspB␣) is present in ␣-proteobacteria (ref. 23 and this work).
We find that SspB␣ binds and delivers ssrA-tagged proteins to C. crescentus ClpXP similarly to previously characterized SspB adaptors (Fig. 3) . Enhancement of degradation depends on a C-terminal tethering motif (QFRKK) conserved among SspB␣ proteins (Fig.  3C) . Although a ClpX-binding motif is also conserved among SspB proteins from ␤-or ␥-proteobacteria, the tethering sequence (LRVVK in E. coli SspB) is substantially different. Because SspB␣ recognizes the C. crescentus ssrA tag but shares only minimal sequence identity with SspB homologs from ␤ and ␥-proteobacteria, we suggest that the functional interaction between SspB/ssrA pairs has been selected for during the evolution of the proteobacteria. Understanding how this highly divergent sequence results in a similar affinity for substrate and a similar capacity to enhance degradation should improve our ability to identify new adaptors.
Finally, degradation of the adaptor itself in the absence of substrate (Fig. 3D) would naturally limit the presence of the adaptor to times in the cell cycle when it is actively aiding in substrate degradation, similar to the self-limiting function identified in certain E2 ligases (32) . Indeed, we observed a 3-fold decrease in steady-state SspB␣ levels in vivo when the ssrA gene was deleted (data not shown), consistent with our observation of ClpXP degradation of SspB␣ in the absence of ssrA-tagged substrates in vitro. Levels of SspB␣ transcripts vary substantially in a cell-cycle-dependent fashion in vivo, but SspB␣ protein levels remain relatively constant (ref. 23 and our unpublished observations). This apparent disparity could be explained if cell-cycle-dependent changes in the rate of SspB␣ degradation, caused by fluctuating levels of SspB␣-dependent substrates, were offset by changes in the rate of SspB␣ synthesis.
A key regulator of the cell cycle in C. crescentus is CtrA, which silences the origin of replication and controls transcription of numerous cell-cycle-regulated genes. Degradation of CtrA is a highly specific event, only occurring before initiation of DNA replication. Localization and proper cell-cycle degradation of CtrA in vivo appear linked and require the presence of its N-terminal receiver domain and RcdA (14, 33) . Our results, however, show clearly that CtrA is efficiently degraded in an RcdA-independent reaction by purified ClpXP alone, with kinetics that account for the intracellular rate of CtrA degradation (Fig. 2) . Furthermore, neither RcdA nor the N-terminal domain of CtrA is required for direct recognition of CtrA by ClpXP in vitro, suggesting that this factor and auxiliary domain play other roles in the more complex intracellular environment.
Why is CtrA not degraded during some stages of the cell cycle even though ClpXP is constitutively present (10)? Our biochemical experiments indicate that an adaptor is not necessary for CtrA degradation, making current models that posit regulated adaptorlike proteins unlikely. Instead, we propose that control of CtrA degradation may involve an inhibitory mechanism that is present in the swarmer and predivisional cell types. For example, CtrA might be bound to a protein that inhibits degradation by masking the C-terminal recognition motif directly or indirectly. This inhibitorCtrA complex could require the N-terminal domain of CtrA and be disrupted by RcdA, explaining why requirements for these factors differ in vivo and in vitro (Fig. 5A) .
A second model to explain cyclic CtrA turnover is that ClpXP itself is inhibited during certain stages of the cell cycle. Our results show that competition between direct and adaptormediated substrates could provide such a mechanism if the amount of ClpXP were limiting (Fig. 5B) . Indeed, levels of ClpXP in vivo are at least 10-fold lower than CtrA, which is only one of many substrates for this protease. An appealing attribute of this model is that there is no need to invoke a single inhibitor. Instead, all adaptor-substrate complexes would collectively act to inhibit degradation of CtrA and other directly recognized substrates until the higher-priority substrates were eliminated. The availability of purified C. crescentus ClpXP will undoubtedly be useful in elucidating mechanisms underlying regulated and targeted substrate turnover.
Materials and Methods
Plasmids and Strains. With the exception of GFP and thioredoxinHis 6 -tagged CtrA or variants, all plasmids were based on the pET28b vector that appends an N-terminal His 6 -tag and thrombin site to the target protein under T7-promoter control. These plasmids were transformed into E. coli BL21(DE3) for expres- sion. GFP constructs were cloned into a pBAD system for arabinose-inducible expression and transformed into E. coli lacking the clpX, clpP, and clpA genes (W3110 ⌬clpXP⌬clpA).
Purification. Purification of C. crescentus ClpX was performed by using a version of ClpX (CCX) with an N-terminal His 6 tag and then a thrombin cleavage site. Briefly, BL21(DE3) E. coli harboring pET28b-CCX were grown in Luria broth supplemented with 50 g/ml kanamycin to a final OD 600 of 0.4-0.6 at 30°C, and isopropyl ␤-D-thiogalactoside was then added to 0.4 mM to induce expression for 2-4 h. Cells were harvested by using centrifugation and resuspended in 3 ml of lysis buffer (50 mM Tris⅐HCl, pH 8.2/100 mM KCl/1 mM MgCl 2 /1 mM DTT/10% glycerol) per gram of wet cell weight, and then frozen in liquid nitrogen until purification.
Typical purifications involved thawing 20 ml of cell suspension by adding an additional 10 ml of cold lysis buffer plus protease inhibitors (Protease Inhibitor Mixture III; Calbiochem, San Diego, CA). Cells were kept at 4°C until they were disrupted by using a French press [15,000 psi (1 psi ϭ 6.89 kPa)], and the lysate was cleared by using centrifugation at 30,000 ϫ g for 20 min at 4°C. The supernatant was applied to a 1.5-ml Ni-NTA agarose (Qiagen, Valencia, CA) column preequilibrated in lysis buffer. The column was washed with 20 volumes of lysis buffer plus 20 mM imidazole, then 30 volumes of lysis buffer plus 20 mM imidazole and 0.5 M KCl, followed by a final wash with 30 volumes of lysis buffer plus 20 mM imidazole without additional salt. The column resin was then resuspended in 10 ml of lysis buffer plus 20 mM imidazole, and 15 units of recombinant thrombin (EMD Biosciences, San Diego, CA) was added. After cleavage for 2 h on ice with gentle rocking, the suspension was poured into an empty column and the flow-through fraction was collected and combined with two additional 10-ml washes of lysis buffer plus 20 mM imidazole. This material was immediately applied to a 1-ml monoQ column (GE Healthcare, Chalfont St. Giles, U.K.) equilibrated in lysis buffer plus 5 mM DTT (buffer QA). After washing with buffer QA, a 40-min gradient of 0-60% QB (buffer QA plus 1 M KCl) with a flow rate of 1 ml/min was applied. ClpX eluted as a single peak at Ϸ20% QB. Fractions containing pure ClpX (as assayed by SDS/PAGE) were pooled and concentrated by using filter centrifugation (Millipore, Billerica, MA), and aliquots were frozen in liquid nitrogen and stored at Ϫ80°C.
C. crescentus ClpP-His 6 was purified in a fashion similar to that of E. coli ClpP-his6 (24) . Briefly, DH5␣ harboring a variant of lactose-inducible plasmid pQE70 (Qiagen) expressing C. crescentus ClpP with a C-terminal His 6 tag (pQE70-CCP) was grown at 30°C overnight. Cells were harvested and lysed, and purification was performed by using Ni-NTA agarose (24) followed by gel-filtration on a HiPrep 26/60 Sephacryl-200 column (GE Healthcare).
RcdA, SspB␣, and SspB␣⌬5 were purified from BL21(DE3) expressing pET28bRcdA, pET28CCsspB, and pET28CCsspB157. After purification by using Ni-NTA agarose resin, proteins were cleaved from the N-terminal affinity tag by using thrombin cleavage in solution, followed by further purification by using anionexchange chromatography or subsequent passage over Ni-NTA agarose to remove the cleaved tag. CtrA was purified in two ways. Thioredoxin-His 6 -tagged versions of CtrA and CtrA-DD were purified according to previously published protocols (34) . Nterminally His 6 -tagged CtrA and CtrA (117-232) were purified from pET28-based vectors in a manner similar to that described above. Although affinity tags were generally retained, removal of the tags by using site-specific cleavage did not affect degradation of the substrates. GFP substrates were purified according to previously published protocols (35) . All proteins were Ͼ95% pure as judged by SDS/PAGE. Protein Degradation Reactions. All degradation reactions were performed in PD buffer [25 mM Hepes⅐KOH/5 mM MgCl 2 /5 mM KCl/15 mM NaCl/0.032% (vol/vol) Nonidet P-40/10% glycerol, pH 7.6] supplemented with an ATP regeneration system (25) . GFP degradation was performed as described (25) with the exception that fluorescence was monitored by using a fluorimeter (Photon Technology International, Lawrenceville, NJ) with excitation at 480 nm and emission at 515 nm and typically with volumes of 60 l at 30°C. Degradation of CtrA and SspB␣ was performed in a 30°C heat block, and samples were removed at different times, quenched by addition of 5ϫ SDS/PAGE sample buffer (40 mM DTT/0.2 M Tris, pH 8.0/1% SDS/30% glycerol) to 1ϫ and frozen on dry ice. After completion of the experiment, samples were heated at 95°C for 5 min and resolved on 12% or 15% SDS/PAGE gels. Samples were stained with Coomassie blue and destained in distilled water, and then images were produced by using an Epson (Long Beach, CA) 3200 scanner. Intensities of substrate bands were analyzed by using ImageQuantTL (GE Healthcare).
Protein Denaturation and Fluorescence Anisotropy. Tryptophan fluorescence was monitored by using a fluorimeter (Photon Technology International) with excitation set at 280 nm, and emission was scanned from 290 to 450 nm. A 50-l sample of 2.5 M RcdA in 20 mM Hepes⅐KOH/100 mM KCl (pH 8.0) was scanned initially. Increasing volumes of 2.5 M RcdA in 20 mM Hepes⅐KOH/100 mM KCl/6 M GuHCl (pH 8.0) were then added, resulting in a gradual increase in denaturant concentration. After each addition, another fluorescence emission scan was performed after equilibration. The center of mass of fluorescence was calculated from the resulting scans. Fluorescence anisotropy of fluorescein-labeled C. crescentus ssrA peptide with an N-terminal solubilization sequence (FITC-AKKGRHGAANDNFAEEFAVAA; MIT CCR Biopolymers Laboratory, Cambridge, MA) was monitored by using a fluorimeter (Photon Technology International). A 50 nM sample of labeled peptide was incubated with increasing amounts of SspB␣ in 20 mM Hepes⅐KOH/100 mM KCl (pH 8.0). Excitation and emission were set at 490 and 520 nm, respectively, and the slit widths were set to 8 nm.
